These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 2418848

  • 1. Recombinant human interferons.
    Otto B.
    Arzneimittelforschung; 1985; 35(11):1750-2. PubMed ID: 2418848
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interferons: chemical properties.
    Fantes KH.
    Tex Rep Biol Med; 1985; 41():240-9. PubMed ID: 6184810
    [Abstract] [Full Text] [Related]

  • 4. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M.
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of antiviral activities of porcine interferon type I and type II].
    Chen X, Xue Q, Zhu R, Fu X, Yang L, Sun L, Liu W.
    Sheng Wu Gong Cheng Xue Bao; 2009 Jun; 25(6):806-12. PubMed ID: 19777805
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polypeptide induction by recombinant human IFN-gamma.
    Weil J, Epstein CJ, Epstein LB.
    Nat Immun Cell Growth Regul; 2009 Jun; 3(1):51-60. PubMed ID: 6431271
    [Abstract] [Full Text] [Related]

  • 14. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
    Vita JR, Edwalds GM, Gorey T, Housepian EM, Fetell MR, Guarini L, Langer JA, Fisher PB.
    Anticancer Res; 1988 Jun; 8(3):297-302. PubMed ID: 2839097
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Purification and structural analysis of interferon.
    Rubinstein M.
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep 24; 299(1094):39-50. PubMed ID: 6183694
    [Abstract] [Full Text] [Related]

  • 17. Construction of expression vectors for secretion of human interferons by yeast.
    Hitzeman RA, Chang CN, Matteucci M, Perry LJ, Kohr WJ, Wulf JJ, Swartz JR, Chen CY, Singh A.
    Methods Enzymol; 1986 Sep 24; 119():424-33. PubMed ID: 3020352
    [No Abstract] [Full Text] [Related]

  • 18. [Isolation and properties of genetic engineered human leukocyte interferons alphaI1 and alphaN].
    Eremashvili MR, Borukhov SI, Bakhutashvili VI, Naroditskaia VA, Chistoserdov AIu.
    Biokhimiia; 1988 Jan 24; 53(1):150-7. PubMed ID: 3358962
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of mammalian DNA polymerases by recombinant alpha-interferon and gamma-interferon.
    Tanaka M, Kimura K, Yoshida S.
    Cancer Res; 1987 Nov 15; 47(22):5971-4. PubMed ID: 3117359
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.